N'-Nicotinamide Methyltransferase (NNMT) Inhibitor Screening Assay Kit

• Cat.No.: Kit-2215
• Product Overview: N′-Nicotinamide Methyltransferase (NNMT) (E.C. 2.1.1.1) catalyzes the N-methylation of nicotinamide, pyridines, and other analogues using S-adenosyl methionine (SAM) as the donor resulting in the production of 1-methylnicotinamide (MNA). NNMT plays a significant role in the regulation of metabolic pathways and is expressed at markedly high levels in several kinds of cancers, neurodegenerative diseases, obesity and diabetes, indicating it is a potential molecular target for therapy. NNMT inhibitor screening kit utilizes SAM as the methyl group donor and nicotinamide as the substrate. NNMT methylates nicotinamide generating S-adenosylhomocysteine (SAH) and 1-methylnicotinamide. The SAH is hydrolyzed by SAH hydrolase to form homocysteine, the free thiol group of which is detected using a Thiol Detecting Probe generating enhanced fluorescence signal that can be measured at Ex/Em = 392/482 nm. In the presence of an NNMT inhibitor, the enzymatic activity is inhibited resulting in decreased fluorescence. This assay kit is a simple, sensitive, and rapid tool to screen potential inhibitors of NNMT.

Specification

• Applications: Screening/studying/characterizing potential inhibitors of NNMT.
• Storage: -80°C
• Shipping: Dry Ice
• Size: 100 assays
• Kit Components: NNMT Assay Buffer; NNMT Enzyme; S-Adenosylmethionine (SAM); Nicotinamide; Enzyme-I; Enzyme-II; 1-Methylnicotinamide (MNA) (150 mM); Thiol Detecting Probe (DMSO); SAM Reconstitution Buffer
• Target Species: Mammalian
• Detection method: Fluorescence (Ex/Em = 392/482 nm)
• Features & Benefits: Rapid assay and simple protocol;
  Reliable test for screening potential inhibitors of NNMT;
  Includes Inhibitor Control, 1-Methylnicotinamide (MNA)
• Tag: Non